In Vivo Efficacy Models CROs
43 published
43 published CROs match In Vivo Efficacy Models.
Locations in this set include United States, China, France, India, Italy, and United Kingdom.
Capabilities that show up most often in this set: Small Molecule, Biologics (Monoclonal Antibodies), Cell Therapy, Biologics (Other), and Gene Therapy.
Matching companies
TigermedLeading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
VIRSCIOVirscio is a preclinical CRO offering non-human primate studies, histopathology, and molecular biology services. It supports IND-enabling efficacy, safety, and PK/PD programs in CNS, ophthalmology, and cardiometabolic areas.
WuXi AppTecGlobal CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Markdown mirror: /services/in-vivo-efficacy-models.md